You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2025

Drugs Containing Excipient (Inactive Ingredient) SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE excipient, and estimated key patent expiration / generic entry dates

CompanyTradenameIngredientNDCExcipientPotential Generic Entry
Medi-Physics Inc ADREVIEW iobenguane i-123 17156-235 SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
AstraZeneca Pharmaceuticals LP WAINUA eplontersen 0310-9400 SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE 2030-12-21
Akorn ZIOPTAN tafluprost 17478-609 SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry
Showing 1 to 3 of 3 entries

Generic drugs containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE excipient

Market Dynamics and Financial Trajectory for Sodium Phosphate, Monobasic, Dihydrate

Introduction

Sodium phosphate, monobasic, dihydrate is a versatile chemical compound with applications spanning multiple industries, including pharmaceuticals, food and beverages, and more. This article delves into the market dynamics and financial trajectory of this compound, particularly focusing on its role as a pharmaceutical excipient.

Market Size and Growth

The global sodium phosphate market, which includes various forms of sodium phosphate, is experiencing significant growth. As of 2022, the market size was valued at approximately USD 412.56 million and is projected to reach USD 874.12 million by 2030, with a compound annual growth rate (CAGR) of 9.84% between 2023 and 2030[1].

Pharmaceutical Excipients Market

In the context of pharmaceutical excipients, the market is also on an upward trend. The global market for pharmaceutical excipients was valued at $9.2 billion in 2023 and is expected to grow to $12.4 billion by 2029, at a CAGR of 5.1% from 2024 to 2029[3].

Role in Pharmaceuticals

Sodium phosphate, monobasic, dihydrate is used as a pharmaceutical excipient due to its properties that enhance the solubility, bioavailability, and stability of active pharmaceutical ingredients (APIs). It is particularly valued for its ability to act as a saline laxative, increasing fluid in the small intestine and facilitating bowel movements[5].

Market Drivers

Several factors are driving the demand for sodium phosphate in the pharmaceutical sector:

  • Increasing Chronic Diseases: The rise in chronic diseases such as diabetes, hypertension, and cancer necessitates the development of more effective and patient-friendly drug formulations, which in turn increases the demand for excipients like sodium phosphate[3].
  • Food and Beverage Industry: The use of sodium phosphate as a food additive in the food and beverages industry also contributes to its growing demand. Its water retention and buffering capacity make it an essential component in processed foods[1][4].
  • Population Growth and Changing Consumer Preferences: The increasing population, especially in emerging countries like India and China, and the changing food preferences of consumers are driving the demand for processed foods, which in turn boosts the demand for sodium phosphate[1][4].

Market Restraints

Despite the positive growth trends, there are several challenges facing the sodium phosphate market:

  • Reduced Supply of Phosphate: The reduced supply of phosphate due to various environmental and regulatory factors can impact the production and availability of sodium phosphate[1][4].
  • Regulatory Restrictions: Strict regulations, particularly those related to the use of sodium phosphate in detergents, can limit market growth. Additionally, the stringent regulatory environment surrounding excipient approval and usage in pharmaceuticals can be a significant hurdle[1][3][4].

Regional Market Dynamics

The global sodium phosphate market is geographically diversified, with the Asia Pacific region holding the major market share. This is attributed to the growing demand for processed foods and the increasing population in countries like India and China. North America and Europe are also expected to experience significant growth in the coming years[1][4].

Competitive Landscape

The market for sodium phosphate is competitive, with several key players involved:

  • Major Companies: Companies such as S.A. OCP, PJSC PhosAgro AG, EuroChem, Innophos Holdings, Inc., and The Mosaic Company are significant players in the sodium phosphate market. These companies are involved in strategic alliances, research collaborations, and acquisitions to expand their product portfolios and enhance their market presence[1].
  • Innovation and Sustainability: Leading companies in the pharmaceutical excipients market, such as ADM, BASF SE, and Croda International Plc, are driving innovation and sustainability in excipient development. This includes investing in cutting-edge technologies and sustainable practices to set new standards for the industry[3].

Financial Trajectory

The financial trajectory of the sodium phosphate market is promising, with significant growth projected over the next few years:

  • Market Forecast: The global sodium phosphate market is expected to grow from USD 412.56 million in 2022 to USD 874.12 million by 2030, at a CAGR of 9.84%[1].
  • Revenue Growth: Another report estimates the global sodium phosphate market to grow from USD 7.03 billion in 2023 to nearly USD 10.34 billion by 2030, at a CAGR of 5.67%[4].

Applications and Uses

Sodium phosphate, monobasic, dihydrate has a wide range of applications:

  • Pharmaceuticals: As a saline laxative and excipient to enhance API properties[5].
  • Food and Beverages: As a food additive for its water retention and buffering capacity[1][4].
  • Fertilizers: Used in agricultural applications to improve crop production[4].
  • Detergents and Water Treatment: Used in detergents and as a water treatment chemical, although subject to regulatory restrictions[1][4].
  • Metal Finishing and Personal Care: Used in metal finishing processes and in personal care products[4].

Key Takeaways

  • The global sodium phosphate market is growing significantly, driven by increasing demand in the food and beverage industry and pharmaceutical sector.
  • The Asia Pacific region leads the market due to growing demand for processed foods and increasing population.
  • Regulatory restrictions and reduced phosphate supply are key challenges facing the market.
  • Major companies are driving innovation and sustainability in the market.
  • The financial trajectory indicates substantial growth over the next few years.

FAQs

What is the projected market size of the global sodium phosphate market by 2030?

The global sodium phosphate market is projected to reach approximately USD 874.12 million by 2030[1].

What are the primary drivers of the sodium phosphate market?

The primary drivers include the growing demand for processed foods, increasing population, and the need for effective pharmaceutical excipients[1][3][4].

Which region holds the major market share in the global sodium phosphate market?

The Asia Pacific region holds the major market share due to the growing demand for processed foods and the increasing population in countries like India and China[1][4].

What are the challenges facing the sodium phosphate market?

The challenges include reduced supply of phosphate, strict regulations, and the regulatory environment surrounding excipient approval and usage[1][3][4].

What are the various applications of sodium phosphate, monobasic, dihydrate?

Applications include pharmaceuticals, food and beverages, fertilizers, detergents, water treatment, metal finishing, and personal care products[1][4][5].

Sources

  1. Zion Market Research, "Sodium Phosphate Market Size, Share, Growth & Trends 2030".
  2. Sigma-Aldrich, "Sodium phosphate monobasic dihydrate".
  3. BCC Research, "Understanding the Future of Pharmaceutical Excipients".
  4. Maximize Market Research, "Sodium Phosphate Market – Global Industry Analysis and Forecast".
  5. DrugBank Online, "Sodium phosphate, monobasic, dihydrate".

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.